269 related articles for article (PubMed ID: 12190320)
21. Efficacy of 2-hydroxy-3-phenylsulfanylmethyl-[1,4]-naphthoquinone derivatives against different Trypanosoma cruzi discrete type units: Identification of a promising hit compound.
Lara LS; Moreira CS; Calvet CM; Lechuga GC; Souza RS; Bourguignon SC; Ferreira VF; Rocha D; Pereira MCS
Eur J Med Chem; 2018 Jan; 144():572-581. PubMed ID: 29289882
[TBL] [Abstract][Full Text] [Related]
22. Synthesis, Biological Evaluation and Molecular Docking of New Benzenesulfonylhydrazone as Potential anti-Trypanosoma cruzi Agents.
Elizondo-Jimenez S; Moreno-Herrera A; Reyes-Olivares R; Dorantes-Gonzalez E; Nogueda-Torres B; Oliveira EAG; Romeiro NC; Lima LM; Palos I; Rivera G
Med Chem; 2017; 13(2):149-158. PubMed ID: 27396731
[TBL] [Abstract][Full Text] [Related]
23. Sulphur-containing derivatives structurally related to fenoxycarb are potent growth inhibitors against the intracellular form of Trypanosoma cruzi.
Rodriguez JB; Docampo R; Gros EG
Int J Antimicrob Agents; 2000 Jan; 13(3):215-8. PubMed ID: 10724027
[TBL] [Abstract][Full Text] [Related]
24. Second generation of 5-ethenylbenzofuroxan derivatives as inhibitors of Trypanosoma cruzi growth: synthesis, biological evaluation, and structure-activity relationships.
Porcal W; Hernández P; Aguirre G; Boiani L; Boiani M; Merlino A; Ferreira A; Maio RD; Castro A; González M; Cerecetto H
Bioorg Med Chem; 2007 Apr; 15(7):2768-81. PubMed ID: 17287123
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and biological evaluation of 2-methyl-1H-benzimidazole-5-carbohydrazides derivatives as modifiers of redox homeostasis of Trypanosoma cruzi.
Melchor-Doncel de la Torre S; Vázquez C; González-Chávez Z; Yépez-Mulia L; Nieto-Meneses R; Jasso-Chávez R; Saavedra E; Hernández-Luis F
Bioorg Med Chem Lett; 2017 Aug; 27(15):3403-3407. PubMed ID: 28648464
[TBL] [Abstract][Full Text] [Related]
26. Naphthoquinoidal [1,2,3]-triazole, a new structural moiety active against Trypanosoma cruzi.
da Silva EN; Menna-Barreto RF; Pinto Mdo C; Silva RS; Teixeira DV; de Souza MC; De Simone CA; De Castro SL; Ferreira VF; Pinto AV
Eur J Med Chem; 2008 Aug; 43(8):1774-80. PubMed ID: 18045742
[TBL] [Abstract][Full Text] [Related]
27. Trypanocidal activity of (-)-cubebin derivatives against free amastigote forms of Trypanosoma cruzi.
de Souza VA; da Silva R; Pereira AC; Royo Vde A; Saraiva J; Montanheiro M; de Souza GH; da Silva Filho AA; Grando MD; Donate PM; Bastos JK; Albuquerque S; e Silva ML
Bioorg Med Chem Lett; 2005 Jan; 15(2):303-7. PubMed ID: 15603944
[TBL] [Abstract][Full Text] [Related]
28. Conformational restriction of aryl thiosemicarbazones produces potent and selective anti-Trypanosoma cruzi compounds which induce apoptotic parasite death.
Magalhaes Moreira DR; de Oliveira AD; Teixeira de Moraes Gomes PA; de Simone CA; Villela FS; Ferreira RS; da Silva AC; dos Santos TA; Brelaz de Castro MC; Pereira VR; Leite AC
Eur J Med Chem; 2014 Mar; 75():467-78. PubMed ID: 24561675
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of proline analogs as trypanocidal agents through the inhibition of a Trypanosoma cruzi proline transporter.
Sayé M; Fargnoli L; Reigada C; Labadie GR; Pereira CA
Biochim Biophys Acta Gen Subj; 2017 Nov; 1861(11 Pt A):2913-2921. PubMed ID: 28844978
[TBL] [Abstract][Full Text] [Related]
30. Synthesis, 2D-QSAR Studies and Biological Evaluation of Quinazoline Derivatives as Potent Anti-Trypanosoma cruzi Agents.
Bollini M; Bruno AM; Niño ME; Casal JJ; Sasiambarrena LD; Valdez DAG; Battini L; Puente VR; Lombardo ME
Med Chem; 2019; 15(3):265-276. PubMed ID: 30295191
[TBL] [Abstract][Full Text] [Related]
31. Further insights of selenium-containing analogues of WC-9 against Trypanosoma cruzi.
Chao MN; Lorenzo-Ocampo MV; Szajnman SH; Docampo R; Rodriguez JB
Bioorg Med Chem; 2019 Apr; 27(7):1350-1361. PubMed ID: 30808607
[TBL] [Abstract][Full Text] [Related]
32. Chelating agent inhibition of Trypanosoma cruzi epimastigotes in vitro.
Rodrigues RR; Lane JE; Carter CE; Bogitsh BJ; Singh PK; Zimmerman LJ; Molenda JJ; Jones MM
J Inorg Biochem; 1995 Dec; 60(4):277-88. PubMed ID: 8530923
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and biological evaluation of 2-alkylaminoethyl-1,1-bisphosphonic acids against Trypanosoma cruzi and Toxoplasma gondii targeting farnesyl diphosphate synthase.
Szajnman SH; García Liñares GE; Li ZH; Jiang C; Galizzi M; Bontempi EJ; Ferella M; Moreno SN; Docampo R; Rodriguez JB
Bioorg Med Chem; 2008 Mar; 16(6):3283-90. PubMed ID: 18096393
[TBL] [Abstract][Full Text] [Related]
34. Effect of a new anti-T. cruzi metallic compound based on palladium.
Mosquillo MF; Bilbao L; Hernández F; Machado I; Gambino D; Garat B; Pérez-Díaz L
Biometals; 2018 Dec; 31(6):961-974. PubMed ID: 30259247
[TBL] [Abstract][Full Text] [Related]
35. Novel 3-nitro-1H-1,2,4-triazole-based piperazines and 2-amino-1,3-benzothiazoles as antichagasic agents.
Papadopoulou MV; Bloomer WD; Rosenzweig HS; Kaiser M; Chatelain E; Ioset JR
Bioorg Med Chem; 2013 Nov; 21(21):6600-7. PubMed ID: 24012457
[TBL] [Abstract][Full Text] [Related]
36. In-vitro antiproliferative effects and mechanism of action of the bis-triazole D0870 and its S(-) enantiomer against Trypanosoma cruzi.
Liendo A; Lazardi K; Urbina JA
J Antimicrob Chemother; 1998 Feb; 41(2):197-205. PubMed ID: 9533461
[TBL] [Abstract][Full Text] [Related]
37. Identification of novel benzimidazole derivatives as anti-Trypanosoma cruzi agents: solid-phase synthesis, structure-activity relationships and molecular docking studies.
Ríos N; Varela J; Birriel E; González M; Cerecetto H; Merlino A; Porcal W
Future Med Chem; 2013 Oct; 5(15):1719-32. PubMed ID: 24144409
[TBL] [Abstract][Full Text] [Related]
38. Biological activity of the azlactone derivative EPA-35 against Trypanosoma cruzi.
de Azeredo CM; Ávila EP; Pinheiro DL; Amarante GW; Soares MJ
FEMS Microbiol Lett; 2017 Feb; 364(4):. PubMed ID: 28130370
[TBL] [Abstract][Full Text] [Related]
39. Indirubin derivatives are potent and selective anti-Trypanosoma cruzi agents.
Efstathiou A; Meira CS; Gaboriaud-Kolar N; Bastos TM; Rocha VPC; Vougogiannopoulou K; Skaltsounis AL; Smirlis D; Soares MBP
Virulence; 2018; 9(1):1658-1668. PubMed ID: 30387370
[TBL] [Abstract][Full Text] [Related]
40. Activity of Fluorine-Containing Analogues of WC-9 and Structurally Related Analogues against Two Intracellular Parasites: Trypanosoma cruzi and Toxoplasma gondii.
Chao MN; Li C; Storey M; Falcone BN; Szajnman SH; Bonesi SM; Docampo R; Moreno SN; Rodriguez JB
ChemMedChem; 2016 Dec; 11(24):2690-2702. PubMed ID: 27886451
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
